PF
Pfizer Inc.
PFE.NE · NEO
$12.15 -0.41% (-$0.05)
1M -1.69%
Market Cap $143.2B
P/E Ratio 33.01x
Div. Yield 1.57%
ROE 4.90%
Bulios Fair Price
$14.75
21.4% upside
Current Price
$12.15
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PFE.NE is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Strong
7/9Valuation
72 /100
Cheap P/S 2.22x
P/E 33.01x
P/B 1.68x
Growth
1 /100
Declining FCF growth 29.21%
EPS growth 9.71%
Book val. growth 3.37%
Profitability
89 /100
Strong Op. margin 26.27%
Gross margin 70.96%
FCF margin 17.25%
Quality
36 /100
Average ROA 2.16%
ROIC 10.25%
Asset turnover 0.32x
Debt
55 /100
Moderate Int. coverage 5.48x
Debt/Equity 0.74x
Net debt/EBITDA 2.89x
Stability
40 /100
Moderate EPS volatility 198.34%
Beta 0.42x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PFE.NE
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Albert Bourla
Employees
75,000
Headquarters
New York City